Search Within

Hikmat Al-Ahmadie

  1. "Survivorship Research"
Formats
  1. Journal Article (42)
  2. Meeting Abstract (39)
Groups
  1. Department of Pathology and Laboratory Medicine (81)
  2. Survivorship Research (81)
  3. Department of Medicine (75)
  4. Surgery (75)
  5. Solid Tumor Oncology Division (74)
  6. Genitourinary Oncology Service (73)

More Groups

People
  1. David Solit (55)
  2. Gopakumar Iyer (51)
  3. Dean Bajorin (49)
  4. Bernard Bochner (48)
  5. Jonathan Coleman (41)
  6. Jonathan Rosenberg (38)

More People

Years
  1. 2025 (5)
  2. 2024 (10)
  3. 2023 (8)
  4. 2022 (9)
  5. 2021 (6)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (24)
  2. Urologic Oncology: Seminars and Original Investigations (7)
  3. Laboratory Investigation (5)
  4. Cancer Research (4)
  5. Clinical Cancer Research (4)
  6. European Urology (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (28)
  2. Elsevier Inc. (12)
  3. Elsevier Science, Inc. (10)
  4. American Association for Cancer Research (8)
  5. Nature Publishing Group (8)
  6. Nature Research (3)

More Publishers

Results (81)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Re-analysis of intravesical gemcitabine in the era of Bacillus Calmette-Guérin (BCG)-unresponsive non–muscle-invasive bladder cancer
    Journal Article

    De Jesus Escano, M. R.; Vertosick, E. A.; D'Souza, N.; Benfante, N.; Lenis, A. T.; Reisz, P. A.; Gaffney, C.; Goh, A.; Donahue, T. F.; Cha, E.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • Clinical outcomes, genomic heterogeneity, and therapeutic considerations across histologic subtypes of urothelial carcinoma
    Journal Article

    Chu, C. E.; Chen, Z.; Whiting, K.; Ostrovnaya, I.; Lenis, A. T.; Clinton, T. N.; Rammal, R.; Ozcan, G. G.; Akbulut, D.; Basar, M.; more...
    European Urology (2025)

    Fulltext@MSK | Save
  • Oncologic outcomes of retroperitoneal lymph node dissection following first-line chemotherapy for metastatic non-seminomatous germ-cell tumors
    Journal Article

    Matulewicz, R. S.; Baky, F.; Liso, N.; Williams, B. M.; Porwal, S.; Assel, M.; Carver, B. S.; Bajorin, D. F.; Motzer, R. J.; Bosl, G. J.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • Updated long-term follow-up from a phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy for patients with high-grade upper tract urothelial carcinoma
    Meeting Abstract

    Jayalath, V.; Teo, M. Y.; Assel, M.; Rodriguez, D.; Meyerson, A.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Cha, E. K.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Molecular heterogeneity and immune infiltration drive clinical outcomes in upper tract urothelial carcinoma
    Journal Article

    Kim, K.; Alam, S. M.; Kuo, F.; Chen, Z.; Yip, W.; Katims, A. B.; Chu, C.; Lenis, A. T.; Hu, W.; Gokturk Ozcan, G.; more...
    European Urology (2025)

    Fulltext@MSK | Save
  • Neoadjuvant nivolumab (N) + ipilimumab (I) in cisplatin-ineligible patients with upper tract urothelial cancer (UTUC): Updated results
    Meeting Abstract

    Sternschuss, M.; Guercio, B. J.; Pietzak, E. J.; Ponomarev, M.; Regazzi, A. M.; Quinlan, C.; Aggen, D. H.; Goh, A. C.; Cha, E. K.; Donat, S. M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Defining molecular features associated with microsatellite instability and response to immune checkpoint blockade in urothelial carcinoma
    Meeting Abstract

    Alam, S. M.; Teo, M. Y.; Woo, J.; Sarfaty, M.; Funt, S. A.; Aggen, D. H.; Lee, C. H.; Carlo, M. I.; Gandhi, J.; Ratna, N.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Development of a porcine model of bladder cancer using the Oncopig
    Meeting Abstract

    Aulitzky, A.; Vanden Berg, R. W.; Kim, K.; Al-Ahmadie, H.; Monette, S.; Shariat, S.; Coleman, J. A.
    European Urology (2024)

    Fulltext@MSK | Save
  • Natural history and genomic landscape of chemotherapy-resistant muscle-invasive bladder cancer
    Journal Article

    Lenis, A. T.; Whiting, K.; Ravichandran, V.; Tallman, J. E.; Alam, S. M.; Chu, C. E.; De Jesus Escano, M.; Bochner, E.; Katims, A.; Reisz, P. A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • ERBB2 alterations in non-muscle invasive bladder cancer are associated with a distinct genomic signature
    Meeting Abstract

    Alam, S. M.; Tallman, J.; Koll, F.; D'Souza, N.; de Jesus Escano, M.; Donahue, T.; Goh, A.; Sarungbam, J.; Berger, M.; Schultz, N.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save